Targeted Nanobubbles Inhibit Enzalutamide-Resistant Prostate Cancer in Preclinical Models Under Ultrasound
Ultrasound-guided nanobubbles co-delivering siFGFR1 and enzalutamide inhibited drug-resistant prostate cancer cells and reduced tumor growth in preclinical models without observed ...
